Category: "Cannabis Derived Medicine"

NEW CBD for EPILEPSY SURVEY DATA RELEASED!

From May 20 to September 1 2014, Epilepsia conducted an online survey seeking opinions about the use of medical marijuana and cannabidiol (CBD) for people with epilepsy A MINORITY 48% of Specialists (Neurologists and Epileptologists) would recommend using medical marijuana in severe cases of epilepsy and an even smaller amount said that there was enough […]

A New Candian Study Shows Dramatic Success With CBD Treatment for Epilepsy

PRESS RELEASE: VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) — A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy. Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their […]

VIDEO: Charlotte’s Web for Epilepsy Consortium

The Epilepsy Association of Central Florida, EpilepsyU and The Realm of Caring Florida present “Charlotte’s Web: A Consortium for Understanding Florida’s Compassionate Care Law” at Concorde Career Institute, Orlando Florida. Filmed November 15, 2014 Featuring: Chuck Carmen, Director, Epilepsy Association of Central Florida Dr. Ngoc Minh Le, Epileptologist, Pediatric Neurology, P.A. Paige Figi, Founder, Realm […]

Marijuana for Pediatric Seizures?

Pediatric neurologists are being bombarded with questions from patients and families about medical marijuana, but they’re not convinced of the scientific evidence supporting its use in conditions such as intractable epilepsy. Even if they were, they’re somewhat confused about where they stand legally. But many think that the landscape is about to change. Delegates attending […]

Clinical Trial of Epidiolex(R) as a Potential Treatment for Epilepsy in Dravet Syndrome

“The results of our open-label trial of Epidiolex in children with Dravet syndrome have been very encouraging and we are excited to begin this important placebo-controlled clinical trial,” stated Orrin Devinsky MD, Professor of Neurology, Neurosurgery, and Psychiatry at NYU School of Medicine, and Principal Investigator of the trial. “As one of the largest epilepsy […]

Initial Data on ‘Pharma Grade’ Cannabidiol in Epilepsy

Initial data from an open-label study in treatment-resistant epilepsy of pharmaceutical-grade cannabidiol — the nonpsychoactive ingredient in marijuana that is believed to be responsible for its antiepileptic action — suggest that it reduces seizure rate by about 30%. The product, said to be 98% pure cannabidiol, in development under the brand name Epidiolex by GW Pharmaceuticals, which […]

RECENT NEWS